|
Market Closed -
Canadian Securities Exchange
14:30:00 16/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0100 CAD | +100.00% |
|
+100.00% | -83.33% |
| Market Cap | 1.19M 850K 742K 698K 637K 81.52M 1.2M 8.37M 3.22M 41.54M 3.2M 3.13M 134M | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 470K 335K 292K 275K 251K 32.12M 471K 3.3M 1.27M 16.37M 1.26M 1.23M 52.74M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +100.00% | ||
| 1 week | +100.00% | ||
| Current month | +100.00% | ||
| 3 months | -33.33% | ||
| 6 months | -33.33% | ||
| Current year | -83.33% |
| 1 week | 0.01 |  | 0.01 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.25 |
| 3 years | 0 | | 0.25 |
| 5 years | 0 | | 0.6 |
| 10 years | 0 | | 1.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 30/09/2019 |
José Roldan
DFI | Director of Finance/CFO | - | 08/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 30/09/2019 |
Daniel Augereau
BRD | Director/Board Member | 82 | 30/09/2019 |
Eric Klein
BRD | Director/Board Member | 66 | 30/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/06/25 | Sell | Chief Executive Officer | 4,667,000 | 3.9091% | ||
| 21/03/25 | Buy | Chief Executive Officer | 200,000 | 0.1675% | ||
| 21/03/25 | Buy | Chief Executive Officer | 100,000 | 0.0838% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +100.00% | +100.00% | -33.33% | -90.00% | 852K | |
| +1.04% | +4.41% | +54.91% | +104.50% | 1,028B | |
| -0.19% | +1.46% | +52.94% | +65.41% | 651B | |
| +0.20% | +2.86% | +18.88% | +72.18% | 466B | |
| +2.24% | +5.98% | +37.61% | +42.44% | 346B | |
| +0.90% | +3.66% | +18.79% | +25.03% | 266B | |
| +0.48% | +7.28% | +11.11% | +14.70% | 259B | |
| +1.95% | +4.19% | +37.75% | +44.83% | 208B | |
| -7.65% | -5.95% | -33.09% | -60.76% | 191B | |
| +0.30% | +4.76% | +31.97% | +98.58% | 186B | |
| Average | +9.84% | +2.93% | +19.75% | +31.69% | 360.17B | |
| Weighted average by Cap. | +0.07% | +3.09% | +35.56% | +62.43% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.34M 3.09M 2.7M 2.54M 2.32M 296M 4.35M 30.43M 11.71M 151M 11.63M 11.37M 487M | 3.36M 2.39M 2.09M 1.97M 1.79M 229M 3.36M 23.56M 9.06M 117M 9M 8.8M 377M |
| Net income | -16.5M -11.75M -10.26M -9.65M -8.8M -1.13B -16.52M -116M -44.49M -574M -44.19M -43.2M -1.85B | -8.91M -6.34M -5.54M -5.21M -4.75M -608M -8.92M -62.45M -24.02M -310M -23.86M -23.32M -999M |
| Net Debt | -626K -446K -389K -366K -334K -42.73M -626K -4.39M -1.69M -21.77M -1.68M -1.64M -70.15M | -723K -515K -450K -423K -386K -49.4M -724K -5.07M -1.95M -25.17M -1.94M -1.89M -81.11M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- RAMM Stock
Select your edition
All financial news and data tailored to specific country editions
